Navigation Links
Vitamin D No Magic Bullet for Osteoarthritis
Date:11/7/2010

By Steven Reinberg
HealthDay Reporter

SUNDAY, Nov. 7 (HealthDay News) -- People suffering from osteoarthritis of the knee appear to receive no relief from taking vitamin D supplements, U.S. researchers report.

"I've never heard of vitamin D as an intervention strategy," said Dr. Kevin Dalal, an assistant professor of rehabilitation medicine at the University of Miami Miller School of Medicine. "I am not surprised it didn't work. It's a tough process to try to change after it's been going on for years."

He noted that 25 million Americans suffer from osteoarthritis.

"The joints that bear the weight take the brunt of the disease. The joint space starts narrowing, bone spurs develop and the joint becomes very uncomfortable," explained Dalal, who was not involved in the study.

He said the theory behind why vitamin D might work is its ability to increase the absorption of calcium, which might strengthen the knee joint.

The findings were to be presented Sunday at the American College of Rheumatology's annual meeting in Atlanta.

To see if vitamin D might have a beneficial effect, a team led by Dr. Timothy McAlindon, an associate professor of medicine in the division of rheumatology at Tufts New England Medical Center, studied 146 people with osteoarthritis of the knee.

The participants were randomly assigned to take vitamin D or placebo. Those taking vitamin D group started taking 2,000 International Units (IU) daily.

Over the course of the study, doses of vitamin D were increased in 2,000 IU increments to maintain a blood level of the vitamin at more than 30 nanograms per milliliter, the researchers noted.

In addition, McAlindon's team gave the participants physical function tests and X-rayed the affected knee at the start of the study and one year later. They also had the participants undergo an MRI at the start and at the end of the study.

These data helped the researchers keep track of knee cartilage volume and thickness, along with bone marrow lesion volume, to see if there were any changes over time.

After two years, there were no substantial differences between those people taking vitamin D and those taking placebo, the researchers found.

"This study tested whether vitamin D supplementation, given over a two-year period, could influence the rate of progression of joint damage in people with knee osteoarthritis," McAlindon said in a statement. "The study found no difference compared to a placebo treatment."

Osteoarthritis is the most common joint disease affecting middle-age and older people. The condition causes progressive damage to the joint cartilage and causes changes in the structures around the joint, the researchers said.

These changes can include accumulation of fluid, bony overgrowth, and loosening and weakness of muscles and tendons, all of which can limit movement and cause pain and swelling.

Dalal noted that the only treatment for osteoarthritis is physical therapy, exercise and anti-inflammatory medication. Eventually, many people suffering from knee osteoarthritis will need a joint replacement, he said.

Research suggests that other treatments such as glucosamine and other herbal remedies also don't work, Dalal said. "But some people are desperate and try alternatives," he said.

More information

For more information on osteoarthritis, visit the U.S. National Library of Medicine.

SOURCES: Kevin Dalal, M.D., assistant professor, rehabilitation medicine, University of Miami Miller School of Medicine; Nov. 7, 2010, presentation, American College of Rheumatology annual meeting, Atlanta


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. eVitamins Launches New Health Encyclopedia
2. New Multivitamins Target Concern Over China's Quality Problems
3. Vitamin B3 May Help Repair Brain After a Stroke
4. Vitamins stored in bathrooms, kitchens may become less effective
5. Vitamin Shoppe, Inc. To Present at the 2010 Stifel Nicolaus Consumer Conference
6. Vitamin D lifts mood during cold weather months
7. Henry Ford Hospital study shows link between vitamin D, skin cancer
8. Metabolife's New Green Tea + Vitamin D3 Helps Promote Bone Health and Supports Weight Management
9. Boosting Vitamin D Can Do a Heart Good
10. Study: Low Levels of Vitamin D Linked to Higher Rates of Asthma in African American Kids
11. Too Many Infants Short on Vitamin D
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vitamin D No Magic Bullet for Osteoarthritis
(Date:2/24/2017)... ... 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... generation. Yisrayl makes an astounding statement when he says that the entire Bible ... Bible details the current times so plainly that anyone should be able to see ...
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica Communications, a national ... , media relations, social media, content marketing and SEO, is now offering direct, ... an intuitive marketing automation platform. , Rosica will now offer the platform to ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February 22, 2017 ... letter to withdraw previous guidance issued by the Obama Administration requiring schools ... in May 2016 by the Obama Administration came in response to a growing ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is ... KLS is a longtime supporter of the event. , "We are pleased that ... said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017  This report analyzes the worldwide markets for ... Products: Intermediates, Analytical, and Others. The End ... and Agrochemicals. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2022. Also, a six-year historic analysis is provided for ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017  Genesis ... HME Company. The announcement was made by Bill ... David Hartley and Nathan Feltman , ... of Genesis Healthcare Services, LLC. This ... nation,s largest provider of technology enabled durable medical equipment ...
Breaking Medicine Technology: